Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1996;87:380-383
© 1996 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dulitzki, M
Right arrow Articles by Schiff, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dulitzki, M
Right arrow Articles by Schiff, E

Articles

Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies

M Dulitzki, R Pauzner, P Langevitz, M Pras, A Many, and E Schiff

OBJECTIVE: To describe experience with 41 pregnancies treated with the low-molecular-weight heparin enoxaparin. METHODS: The medical charts of 34 women (a total of 41 pregnancies) treated between January 1992 and March 1995 with the low-molecular-weight heparin enoxaparin were reviewed. Most patients (87.5%) received one daily 40-mg injection. In all cases, treatment was continued throughout labor, delivery, and the immediate postpartum period. RESULTS: Therapy was administered for 5-280 days (median 91). One case of a thromboembolic event was recorded during treatment. No systemic or local side effects were reported. During pregnancy, only one patient had mild vaginal bleeding, which resolved spontaneously while therapy was continued. There was no excessive intrapartum bleeding in any of these patients, whether delivered vaginally or abdominally. During treatment, 19 of the 34 patients underwent 24 surgical procedures, including 13 cesarean deliveries, without excessive bleeding. Epidural anesthesia was used during labor in nine of the patients, with no specific complications. The corrected perinatal mortality rate, (ie, the rate of fetal death after 24 weeks' gestation plus neonatal death, excluding a neonate with multiple anomalies) for those neonates delivered after 24 weeks' gestation was 2.7%. There were no cases of intraventricular hemorrhage in any of the neonates. CONCLUSION: This preliminary series, the largest reported to date, demonstrates the relative safety and efficacy of low-molecular-weight heparin therapy in pregnancy and delivery.


This article has been cited by other articles:


Home page
 Obstet GynecolHome page
N. S. Fox, S. K. Laughon, S. D. Bender, D. H. Saltzman, and A. Rebarber
Anti-factor Xa Plasma Levels in Pregnant Women Receiving Low Molecular Weight Heparin Thromboprophylaxis
Obstet. Gynecol., October 1, 2008; 112(4): 884 - 889.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. M. Bates, I. A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 844S - 886S.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
I. A. Greer and C. Nelson-Piercy
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
Blood, July 15, 2005; 106(2): 401 - 407.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
L. M. Huxtable, M. J. Tafreshi, and S. M. Ondreyco
A Protocol for the Use of Enoxaparin During Pregnancy: Results from 85 Pregnancies Including 13 Multiple Gestation Pregnancies
Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 171 - 181.
[Abstract] [PDF]

Home page
 ChestHome page
S. M. Bates, I. A. Greer, J. Hirsh, and J. S. Ginsberg
Use of Antithrombotic Agents During Pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 627S - 644S.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
V. Sephton, R. G. Farquharson, J. Topping, S. M. Quenby, C. Cowan, D. J. Back, and C. H. Toh
A Longitudinal Study of Maternal Dose Response to Low Molecular Weight Heparin in Pregnancy
Obstet. Gynecol., June 1, 2003; 101(6): 1307 - 1311.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. S. Ginsberg, I. Greer, and J. Hirsh
Use of Antithrombotic Agents During Pregnancy
Chest, January 1, 2001; 119(1_suppl): 122S - 131S.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
B.M Weiss and O.M Hess
Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives
Eur. Heart J., January 2, 2000; 21(2): 104 - 115.
[PDF]

Home page
 Arch Intern MedHome page
A. C. Spyropoulos, L. Harrison, and R. S. Liebowitz
Outpatient Protocols for Treatment of Venous Thromboembolism Using Low-Molecular-Weight Heparin: To Treat or Not to Treat at Home
Arch Intern Med, May 24, 1999; 159(10): 1139 - 1140.
[Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
Y. Finkelstein, D. Aloni, A. Kimia, R. Sommer, and L. Sirota
Deep Venous Thrombosis in a Preterm Newborn of a Mother with Activated Protein C Resistance
Clinical Pediatrics, June 1, 1998; 37(6): 373 - 376.
[PDF]

Home page
 JWatch Women's HealthHome page
An Alternative Heparin for Pregnancy
Journal Watch Women's Health, April 1, 1996; 1996(401): 15 - 15.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Obstetricians and Gynecologists.